Macrophage-specific MHCII expression is regulated by a remote Ciita enhancer controlled by NFAT5.
Maria BuxadéHector Huerga EncaboMarta Riera-BorrullLucía Quintana-GallardoPilar López-CotareloMónica TellecheaSara Martínez-MartínezJuan Miguel RedondoJuan Martín-CaballeroJuana María FloresElena BoschJosé Luis Rodríguez-FernándezJose AramburuCristina López-RodríguezPublished in: The Journal of experimental medicine (2018)
MHCII in antigen-presenting cells (APCs) is a key regulator of adaptive immune responses. Expression of MHCII genes is controlled by the transcription coactivator CIITA, itself regulated through cell type-specific promoters. Here we show that the transcription factor NFAT5 is needed for expression of Ciita and MHCII in macrophages, but not in dendritic cells and other APCs. NFAT5-deficient macrophages showed defective activation of MHCII-dependent responses in CD4+ T lymphocytes and attenuated capacity to elicit graft rejection in vivo. Ultrasequencing analysis of NFAT5-immunoprecipitated chromatin uncovered an NFAT5-regulated region distally upstream of Ciita This region was required for CIITA and hence MHCII expression, exhibited NFAT5-dependent characteristics of active enhancers such as H3K27 acetylation marks, and required NFAT5 to interact with Ciita myeloid promoter I. Our results uncover an NFAT5-regulated mechanism that maintains CIITA and MHCII expression in macrophages and thus modulates their T lymphocyte priming capacity.
Keyphrases
- transcription factor
- poor prognosis
- nuclear factor
- dendritic cells
- binding protein
- gene expression
- long non coding rna
- adipose tissue
- toll like receptor
- dna damage
- induced apoptosis
- acute myeloid leukemia
- genome wide identification
- genome wide
- cell death
- cell cycle arrest
- inflammatory response
- regulatory t cells
- endoplasmic reticulum stress